These enzymes thus represent suitable targets for novel anti-tuberculosis strategies, in particular for INH-resistant M. tuberculosis strains, where AhpC is thought to compensate for the decreased catalase-peroxidase KatG activity18, 19. The gene discussed is CAT; the disease is tuberculosis.